An alternative to waiting faithfully and patiently is to
An alternative to waiting faithfully and patiently is to simply e-mail and ask Mr. Bordynuik or JBI what obstacles still stand in the way of profitable full production of the processors. If, as you believe, there is nothing standing in the way and JBI has truly spent the last nine months running both processors on customer feedstock in an attempt to satisfy those skeptical customers, they should correct you and say that all systems are 'Go' and that the processors are engaged to satisfy a customer(s).
I'll also point out again that both Mr. Bordynuik and Mr. Heddle would have to be idiots to not realize that investors need information regarding the true status of P2O. Having to ask basic questions is an insult to everyone but it's better than waiting.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Join the Celebration at the 2025 Audio Description Awards Gala The American Council of the Blind (ACB) warmly invites everyone to participate in the highly anticipated 5th Annual Audio Description Awards Gala. Set to take place in November 2025, this event promises to be a dazzling showcase of talent, creativity, and inclusivity within the media landscape. With a focus on...
Continue Reading
The Alkaline Water Company's Growth in the Midwest Market The Alkaline Water Company, Inc. (OTC: WTER), a prominent name in the beverage industry, is making waves with its latest expansion efforts. With a focus on providing high-quality purified alkaline water enhanced with Himalayan rock salt, the company has recently partnered with Pete's Market, a well-respected...
Continue Reading
SELLAS Life Sciences Takes a Major Step in Pediatric AML Treatment SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) has reached a significant milestone by dosing the first pediatric patient in their ongoing Phase 2 trial of SLS009, a groundbreaking treatment aimed at relapsed/refractory acute myeloid leukemia (r/r AML). This development marks a notable advancement in their...
Continue Reading
Almara Women's Health Launches Innovative Whole-Woman Care Uniting Seven Twin Cities Practices Under One Vision Almara Women's Health is introducing a groundbreaking model of care specifically designed for women of all ages. This newly unified collaboration of healthcare providers is set to transform the way women experience healthcare, ensuring that all aspects of their...
Continue Reading
The Surge of Influencer Marketing Platforms The global influencer marketing platform market is on a significant upward trajectory. This dynamic industry is projected to expand from USD 10.6 billion in 2023 to USD 14.2 billion in just one year, ultimately reaching a colossal USD 50.3 billion by 2028. Such extraordinary growth indicates a CAGR of 37.1% from 2024 to 2028....
Continue Reading
